Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application.

Saghir SA, Frantz SW, Spence MW, Nolan RJ, Lowe ER, Rick DL, Bartels MJ.

Food Chem Toxicol. 2007 Oct;45(10):2047-56. Epub 2007 May 18.

PMID:
17583405
2.

Toxicity and pharmacokinetics of 2-(2-dimethylaminoethoxy)ethanol following cutaneous dosing.

Leung HW, Frantz SW, Ballantyne B.

Food Chem Toxicol. 2002 Jul;40(7):1033-40.

PMID:
12065226
3.

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW.

Nat Med. 2001 Apr;7(4):471-7.

PMID:
11283675
4.

Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.

Frantz SW, Ballantyne B, Leung HW.

Toxicol Ind Health. 1998 May-Jun;14(3):413-28.

PMID:
9569447
7.

Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.

Frantz SW, Beskitt JL, Grosse CM, Tallant MJ, Dietz FK, Ballantyne B.

Drug Metab Dispos. 1996 Aug;24(8):911-21.

PMID:
8869828
8.
9.

Pharmacokinetics of 2-ethyl-1,3-hexanediol. III. In vitro skin penetration comparisons using the excised skin of humans, rats, and rabbits.

Frantz SW, Ballantyne B, Beskitt JL, Tallant MJ, Greco RJ.

Fundam Appl Toxicol. 1995 Nov;28(1):1-8.

PMID:
8566473
10.

Disposition and metabolism of acrylic acid in C3H mice and Fischer 344 rats after oral or cutaneous administration.

Black KA, Beskitt JL, Finch L, Tallant MJ, Udinsky JR, Frantz SW.

J Toxicol Environ Health. 1995 Jul;45(3):291-311.

PMID:
7609004
11.

A tiered approach to pharmacokinetic studies.

Wilson AG, Frantz SW, Keifer LC.

Environ Health Perspect. 1994 Dec;102 Suppl 11:5-11.

12.
13.

Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.

Frantz SW, Beskitt JL, Grosse CM, Tallant MJ, Ballantyne B.

Drug Metab Dispos. 1992 Jan-Feb;20(1):6-18.

PMID:
1346998
14.

Pharmacokinetics of 2-ethyl-1,3-hexanediol. I. Systemic disposition following single intravenous doses in male Fischer 344 rats.

Frantz SW, Grosse CM, Tallant MJ, Ballantyne B.

Drug Metab Dispos. 1991 Sep-Oct;19(5):881-8.

PMID:
1686231
15.

Direct determination of acrylamide in tissue culture solution by liquid chromatography using column switching.

Freshour NL, Langvardt PW, Frantz SW, Dryzga MD.

J Chromatogr. 1985 Oct 18;346:376-81. No abstract available.

PMID:
4086621
16.

Mutagenicity in Salmonella assays of cyclohexane epoxide derivatives.

Frantz SW, van den Eeckhout E, Sinsheimer JE, Yoshihara M, Koreeda M.

Toxicol Lett. 1985 Jun;25(3):265-71.

17.
18.

Bacterial mutagenicity and toxicity of cycloaliphatic epoxides.

Frantz SW, Sinsheimer JE.

Mutat Res. 1981 Sep;90(1):67-78.

Supplemental Content

Loading ...
Support Center